Gokul Laroiaـ (@rayanalc) header
Gokul Laroiaـ (@rayanalc) profile picture

I have a professional background in investment, stocks, and macroeconomic research. An experienced market analyst dedicated to helping investors succeed.

Joined January 2019
$CRWV The selloff is largely driven by rate-hike fears and concerns over financing costs. Upcoming $9B in customer prepayments and the next DDTL could help ease market concerns. With shares near the $40 IPO price, a bottom may be approaching.
157
$POET Delays and supply constraints are affecting the entire optical industry, not just POET. These challenges highlight the growing demand for advanced optical solutions. POET's light-source and Blazar technology could benefit from these industry-wide bottlenecks.
220
$NLST Samsung and Micron deals are just the beginning. Give management time to execute. Recent weakness reflects broader market pressure, not necessarily a change in fundamentals. With new licensing revenue and growing value, the long-term opportunity remains strong.
102
$TGTX Big move after hours! Shares surged nearly 7% to $69.35 after trading lower during the regular session. Buyers are stepping in strong. Could this be the start of another breakout? What do you think?
1
1
377
$INO looks significantly undervalued at current levels. Upcoming revenue growth in Q1 and Q2, combined with stronger execution from management, could drive a major turnaround. The stock may be getting closer to a breakout.
121
$AXSM - If no EX-US deal, then this is in Play. Makes no sense otherwise. Free Revenue share, and up front big payments.
143
$NVDA Wild how much they make and the current price. I’ll buy more next week. Will sell half position at 50% profit and then sell CCs until the rest get called away. Bullish
1
141
$ABCL Three potential catalysts could drive the stock back toward $12–$15: another pharmaceutical partnership, positive ABCL635 regulatory progress, and a possible Fast Track designation. These milestones could strengthen AbCellera’s long-term growth story.
2
299
GameStop common stock is up 24% since CNBC's Jim Cramer rated it as a buy. It's safe to say Cramer is back baby. $GME
122
$ANT some context for all the geniuses on here calling for $10 Bullish
42
$CAPR downtrend. just the approval can change everything short term
550
$SLS Phase 3 REGAL results showed a 9.3-month improvement in median overall survival with galinpepimut-S (24 vs. 14.7 months). The vaccine met its primary survival endpoint, offering new hope for AML patients with limited treatment options. A major milestone for SELLAS!
1
3
174
$GRRR Borrow fees soaring to 169.88%! Short sellers are facing increasingly expensive borrowing costs. With Yotta 1, Yotta 2, and vendor financing updates ahead, could a short squeeze be brewing? Bulls, are you ready?
1
1
7
672
$CAPR The FDA panel’s “fragile” criticism is challenged by the data. Across 913 re-analyses, results consistently favored Capricor, with statistical significance maintained in 104 of 105 patient-removal tests. The findings speak for themselves.
3
865
$BB CrowdStrike may have the spotlight today, but its sales-driven advantage won't last forever. As IoT and Physical AI grow, BlackBerry QNX could become a major winner. The market may be underestimating BB's long-term potential. QNX2000.
3
426
$CLOV is facing heavy selling pressure but remains in the $4–$5 trading range. Key support is around $4.08, with $3.89 as the next downside level. Despite market weakness, I'm not running — I'm adding. Still watching closely. Bullish!
1
8
582
$GANX Articles like this that are industry experts saying that increasing GCase is a potential key for Parkinson’s and Dementia could also help share price. Our KOL has written numerous articles supporting this. Bullish
77
$HTZ Core rental business is improving, while Oro Mobility adds exposure to the fast-growing robotaxi market. Stronger fundamentals + new growth opportunities. Staying patient. Bullish!
2
422
$GME is breaking above previous highs and reclaiming the key $24–$24.70 resistance zone, now turning it into potential support. Momentum is improving, and holding above $25 could open the door to $27 and eventually $28–$29. Bullish. Is another breakout coming?
124
$SRXH Will we be like to have At Thanksgiving, Christmas food on the table?
247